Results 191 to 200 of about 72,150 (302)

The Combination of Xanafide and Cytarabine Has Unique Activity in Acute Myeloid Leukaemia [PDF]

, 2007
Harry P. Erba
openalex   +1 more source

Pharmacovigilance‐Based Identification and Mechanistic Exploration of Periodontitis‐Related Drugs

Journal of Clinical Periodontology, Volume 53, Issue 1, Page 117-126, January 2026.
ABSTRACT Background Periodontitis is a common chronic inflammatory disease. However, drug‐related risks and underlying molecular mechanisms remain underexplored from large real‐world data. Methods We first mined the US Food and Drug Administration Adverse Event Reporting System (FAERS) database to identify drugs disproportionately associated with ...
Wuda Huoshen, Junkai Xiong, Xunmi Ma, Heng Wang, Panyu Cheng, Xinyu Chen, Ge Shuai, Yi Chen, Xinyue Zhang, Chen Sun, Chunhui Li, Rui Shi   +11 more
wiley   +1 more source

A relapsed/refractory acute promyelocytic leukemia achieving complete response after chemotherapy with venetoclax. [PDF]

Medicine (Baltimore)
Zhang X, Hao S, Hu C, Qu R.
europepmc   +1 more source

The past is the future: innovative designs in acute stroke therapy trials [PDF]

, 2005
Berry, D.A., Krams, M., Lees, K.R.
core   +1 more source

Myelodysplastic Syndrome With Complex Chromosomal Karyotype Abnormalities Complicated by Multiple Intestinal Perforations: A Case Report and Literature Review

Case Reports in Gastrointestinal Medicine, Volume 2026, Issue 1, 2026.
Background Myelodysplastic syndromes (MDSs) are clonal hematopoietic disorders often associated with cytogenetic abnormalities, among which trisomy 8 is one of the most common abnormalities. Trisomy 8 is linked to autoimmune manifestations, including Behçet‐like disease, especially with gastrointestinal involvement.
Zhan-Yue Niu, Ming-Fei Zhu, Ming Tao, Cheng Zhang, Fang Gu, Jun Li, MARCEL CC MACHADO   +6 more
wiley   +1 more source

Unveiling and stratifying cell cycle-dependent drug efficacy using a single-cell PLOM-CON approach with correlation anomaly and presage protein signals. [PDF]

Commun Biol
Noguchi Y, Kunishige R, Shinozaki-Narikawa N, Yamashita H, Aihara K, Murata M, Kano F.   +6 more
europepmc   +1 more source

Survival Analysis of Gimema AML1718, a Safety Run-in and Phase 2 Open-Label Study of Venetoclax, Fludarabine, Idarubicin and Cytarabine (V-FLAI) in the Induction Therapy of Non Low-Risk Acute Myeloid Leukemia [PDF]

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio, Cristina Papayannidis, Fabio Guolo, Marco Cerrano, Valentina Arena, Saveria Capria, Michela Rondoni, Matteo Giovanni Della Porta, Germana Beltrami, Monica Bocchia, Albana Lico, Luisa Giaccone, Marianna Rossi, Catello Califano, Matteo Giovanni Carrabba, Chiara Cattaneo, Marco Frigeni, Maria Chiara Di Chio, Bianca Serio, Roberto Freilone, Antonio Curti, Paola Minetto, Giovanni Marsili, Clara Minotti, Beatrice Anna Zannetti, Francesca Cotugno, Jacopo Nanni, Giorgia Simonetti, Maria Teresa Bochicchio, Sara Rosellini, Elisabetta Tedone, Adriano Venditti, Roberto M. Lemoli, Marco Vignetti, Paola Fazi, Giovanni Martinelli   +37 more
openalex   +1 more source

Successful Zanubrutinib Monotherapy in a Rare CNS Presentation of Relapsed CLL

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Background Central nervous system (CNS) involvement is an infrequent complication of chronic lymphocytic leukemia (CLL), occurring in less than 1% of cases. We report a case of a 63‐year‐old male with a history of CLL previously treated with ibrutinib but discontinued early due to intolerance. As a result, the patient was then treated with obinutuzumab
Vishaal Kunta, Mohammad Ammad-Ud-Din, Melanie Mediavilla-Varela, Javier Pinilla-Ibarz, Yoshito Nishimura   +4 more
wiley   +1 more source

Evolution of conditioning regimens prior to autologous stem cell transplantation in lymphoma patients. [PDF]

Transl Oncol
Tian H, Wang R, Cong D, Bai Y, Zhang W.
europepmc   +1 more source

Relapse of Acute Myeloid Leukemia With Concomitant Systemic Mastocytosis Five Years Post Allogenic Hematopoietic Stem Cell Transplantation

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Systemic mastocytosis (SM) with associated hematological neoplasia (SM‐AHN) is a rare and aggressive condition characterized by abnormal clonal proliferation of mast cells and the concurrent occurrence of hematologic malignancies, such as acute myeloid leukemia (AML).
Sona Vardanyan, Hilde K. Gjelberg, Lars Helgeland, Galina Tsykunova, Rakel Brendsdal Forthun, Håkon Reikvam, Stephen E. Langabeer   +6 more
wiley   +1 more source